Tenaya Therapeutics Ownership | Who Owns Tenaya Therapeutics?

Tenaya Therapeutics Ownership Summary

Tenaya Therapeutics is owned by 27.86% institutional investors, 0.56% insiders, and 71.58% retail investors. Column group is the largest institutional shareholder, holding 5.75% of TNYA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.98% of its assets in Tenaya Therapeutics shares.

TNYA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Tenaya Therapeutics	27.86%	0.56%	71.58%
Sector	Healthcare Stocks	232.86%	10.65%	-143.51%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Column group	9.40M	5.75%	$6.69M
Vanguard group	8.56M	5.24%	$6.09M
Blackrock	4.07M	5.03%	$12.63M
Empery asset management, lp	5.41M	3.31%	$3.85B
Blackrock funding, inc. /de	3.95M	2.42%	$2.81M
Ghost tree capital	1.35M	1.67%	$4.18M
Renaissance	1.85M	1.13%	$1.32M
Gsa capital partners llp	1.48M	0.91%	$1.05M
Geode capital management	1.19M	0.73%	$849.41K
Raiffeisen bank	1.00M	0.65%	$620.00K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Column group	9.40M	8.08%	$6.69M
Empery asset management, lp	5.41M	3.40%	$3.85B
Ghost tree capital	1.35M	1.31%	$4.18M
Euclidean capital	1.02M	0.69%	$1.65M
Stepstone group lp	462.16K	0.35%	$748.70K
Diadema partners lp	315.52K	0.13%	$511.14K
Gsa capital partners llp	1.48M	0.09%	$1.05M
Mirador capital partners lp	886.92K	0.09%	$614.10K
Persistent asset partners	72.49K	0.08%	$117.44K
Alphabet	915.71K	0.06%	$1.48M

Top Buyers

Holder	Shares	% Assets	Change
Empery asset management, lp	5.41M	3.40%	5.41M
Vanguard group	8.56M	0.00%	3.50M
Blackrock funding, inc. /de	3.95M	-	1.62M
Gsa capital partners llp	1.48M	0.09%	1.02M
Ghost tree capital	1.35M	1.31%	575.00K

Top Sellers

Holder	Shares	% Assets	Change
Ra capital management	-	-	-6.98M
Woodline partners lp	-	-	-5.92M
Octagon capital advisors lp	-	-	-2.58M
Integral health asset management	-	-	-2.38M
Vr adviser	-	-	-1.56M

New Positions

Holder	Shares	% Assets	Change	Value
Empery asset management, lp	5.41M	3.40%	5.41M	$3.85B
Schonfeld strategic advisors	465.96K	0.00%	465.96K	$754.85K
Diadema partners lp	315.52K	0.13%	315.52K	$511.14K
Xtx topco	97.84K	0.01%	97.84K	$158.50K
Persistent asset partners	72.49K	0.08%	72.49K	$117.44K

Sold Out

Holder	Change
Capital performance advisors llp	-12.00
Srs capital advisors	-60.00
Clearstead advisors	-82.00
Rise advisors	-485.00
Smartleaf asset management	-612.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	68	-27.66%	45,507,062	31.79%	27	6.19%	37	8.82%	15	-53.13%
Sep 30, 2025	91	-	34,496,870	9.27%	21	5.63%	34	-24.44%	31	29.17%
Jun 30, 2025	91	-14.95%	31,571,278	-34.46%	19	1.01%	44	-16.98%	25	-21.88%
Mar 31, 2025	2	-97.70%	32,748	-99.92%	-	0.00%	1	-97.92%	1	-94.74%
Dec 31, 2024	49	-47.31%	18,984,954	-67.06%	22	0.49%	29	-43.14%	9	-47.06%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	6.48M	2.98%	-
US Small-Cap Growth II Equity Comp	2.10M	2.66%	-471.71K
T. Rowe Price New Horizons	2.10M	2.65%	-441.00
Fidelity Select Biotechnology	1.75M	2.20%	-
JPMorgan US Small Company L	785.69K	0.91%	-315.70K
Vanguard Institutional Extnd Mkt Idx Tr	1.77M	0.82%	668.34K
T. Rowe Price New Horizons Tr-Z	554.73K	0.70%	9.11K
iShares Biotechnology ETF	1.20M	0.55%	2.49K
Raiffeisen-Health&Wellbeing-ESG Akt A	1.00M	0.46%	1.00M
Fidelity Small Cap Index	608.02K	0.37%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 25, 2026	COLUMN GROUP III GP, LP	-	Sell	$1.05M
Feb 24, 2026	COLUMN GROUP III GP, LP	-	Sell	$190.27K
Feb 24, 2026	COLUMN GROUP III GP, LP	-	Sell	$214.87K
Feb 20, 2026	COLUMN GROUP III GP, LP	-	Sell	$170.80K
Feb 23, 2026	COLUMN GROUP III GP, LP	-	Sell	$96.92K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	20
2025 Q4	-	3
2025 Q3	-	9
2025 Q2	-	3
2025 Q1	6	8

TNYA Ownership FAQ

Who Owns Tenaya Therapeutics?

Tenaya Therapeutics shareholders are primarily institutional investors at 27.86%, followed by 0.56% insiders and 71.58% retail investors. The average institutional ownership in Tenaya Therapeutics's industry, Biotech Stocks , is 382.13%, which Tenaya Therapeutics falls below.

Who owns the most shares of Tenaya Therapeutics?

Tenaya Therapeutics’s largest shareholders are Column group (9.4M shares, 5.75%), Vanguard group (8.56M shares, 5.24%), and Blackrock (4.07M shares, 5.03%). Together, they hold 16.03% of Tenaya Therapeutics’s total shares outstanding.

Does Blackrock own Tenaya Therapeutics?

Yes, BlackRock owns 5.03% of Tenaya Therapeutics, totaling 4.07M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 12.63M$. In the last quarter, BlackRock decreased its holdings by -627K shares, a -13.34% change.

Who is Tenaya Therapeutics’s biggest shareholder by percentage of total assets invested?

Column group is Tenaya Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.08% of its assets in 9.4M Tenaya Therapeutics shares, valued at 6.69M$.

Who is the top mutual fund holder of Tenaya Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Tenaya Therapeutics shares, with 2.98% of its total shares outstanding invested in 6.48M Tenaya Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools